Header graphic for print
Class Action Blog Tp provide current legal information relating to class action lawsuits, including consumer fraud, consumer protection, securities and antitrust class actions

FDA Issues Warning About Safety Of DMAA

DMAA (1, 3 Dimethylamylamine) is marketed as a natural stimulant in dietary supplements, but in a recent report by the FDA, warning letters have been issued to ten manufacturers and distributors of dietary supplements containing DMAA.  The warning letters explain that DMAA  may be produced synthetically, and, as such, the FDA does not consider DMAA a dietary ingredient (such as vitamins or minerals).  According to an FDA statement, “DMAA is known to narrow the blood vessels and arteries, which can elevate blood pressure and may lead to cardiovascular events ranging from shortness of breath and tightening in the chest, to heart attack.”  While there are no specific reports of adverse reactions that can be traced to products containing DMAA, there are reports of nervous system and cardiac disorders, psychiatric disorders, and even death in people who have taken products containing DMAA.  Further, the FDA has reported that in March, two Army soldiers, who reportedly took DMAA products, died unexpectedly during fitness exercises.

A list of manufacturers/distributors, who have received the FDA warning letter are:

  •  Exclusive Supplements (Biorhythm SSIN  Juice)
  • Fahrenheit Nutrition (Lean Efx
  • Gaspari Nutrition (Spirodex)
  • iSatori Global Technologies, LLC (PWR)
  • Muscle Warfare, Inc. (Napalm)
  • MuscleMeds Performance Technologies (Code Red)
  • Mutrex Research (Hemo Rage Black, Lipo-6 Black Ultra Concentrate, Lipo-6 Black, Lipo-6 Black Hers Ultra Concentrate, and Lipo-6 Black Hers)
  • SEI Pharmaceuticals (MethylHex 4,2)
  • SNI LLC (Nitric Blast)
  • USP Labs, LLC (Oxy Elite Pro Jack3D)

If you, or someone you know, have taken DMAA products and have experienced an adverse reaction described above, please call us to discuss your legal options.